CY1123109T1 - Σκευασμα φωσφομυκινης για παρεντερικη χορηγηση - Google Patents
Σκευασμα φωσφομυκινης για παρεντερικη χορηγησηInfo
- Publication number
- CY1123109T1 CY1123109T1 CY20201100110T CY201100110T CY1123109T1 CY 1123109 T1 CY1123109 T1 CY 1123109T1 CY 20201100110 T CY20201100110 T CY 20201100110T CY 201100110 T CY201100110 T CY 201100110T CY 1123109 T1 CY1123109 T1 CY 1123109T1
- Authority
- CY
- Cyprus
- Prior art keywords
- fosfomycin
- parenteral administration
- present
- administration
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/06—Ampoules or carpules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Saccharide Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Ο τομέας της παρούσας εφεύρεσης είναι αυτός των σκευασμάτων φωσφομυκίνης για παρεντερική χορήγηση, ειδικότερα ενδοφλέβια χορήγηση. Τα σκευάσματα στο τελευταίο στάδιο της τεχνικής παρέχουν φωσφομυκίνη σαν σκόνη για αραίωση άμεσα πριν από τη χορήγηση. Σκοπός της εφεύρεσης είναι η διάθεση ενός σκευάσματος φωσφομυκίνης για παρεντερική χορήγηση, το οποίο είναι ευκολότερο να παραχθεί και να χορηγείται ή το οποίο μειώνει τον κίνδυνο τραυματισμών νύξης για το εξειδικευμένο ιατρικό προσωπικό και τους κινδύνους για την υγεία των ασθενών (για παράδειγμα, λόγω μόλυνσης ή εσφαλμένης δοσολογίας) με αποφυγή πρόσθετων σταδίων κατεργασίας. Στο πλαίσιο της παρούσας εφεύρεσης διαπιστώθηκε απροσδόκητα ότι η φωσφομυκίνη είναι πολύ περισσότερο σταθερή σε υδατικό διάλυμα από αυτό που συνήθους θεωρείται. Η παρούσα εφεύρεση επομένως παρέχει ένα κλειστό δοχείο, το οποίο περιέχει ένα υδατικό διάλυμα για παρεντερική χορήγηση, όπου τουλάχιστον ένα φαρμακευτικά αποδεκτό άλας φωσφομυκίνης, ειδικότερα δινάτριο άλας φωσφομυκίνης, και ένα φαρμακευτικά αποδεκτό οξύ. ειδικότερα ηλεκτρικό οξύ, διαλύονται στο διάλυμα. Προτιμητέα δοχεία είναι θραύσιμες αμπούλες από πλαστικό ή γυαλί, φιαλίδιο, σάκοι έγχυσης ή προγεμισμένες σύριγγες.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16160698.3A EP3219305A1 (de) | 2016-03-16 | 2016-03-16 | Fosfomycin-formulierung zur parenteralen verabreichung |
PCT/EP2017/056252 WO2017158099A1 (de) | 2016-03-16 | 2017-03-16 | Fosfomycin-formulierung zur parenteralen verabreichung |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1123109T1 true CY1123109T1 (el) | 2021-10-29 |
Family
ID=55637175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20201100110T CY1123109T1 (el) | 2016-03-16 | 2020-02-05 | Σκευασμα φωσφομυκινης για παρεντερικη χορηγηση |
Country Status (21)
Country | Link |
---|---|
US (2) | US10675291B2 (el) |
EP (3) | EP3219305A1 (el) |
JP (1) | JP2019511573A (el) |
KR (1) | KR20180122346A (el) |
CN (1) | CN108883062A (el) |
AU (1) | AU2017235463A1 (el) |
BR (1) | BR112018068510A2 (el) |
CA (1) | CA3014503A1 (el) |
CY (1) | CY1123109T1 (el) |
DK (1) | DK3419598T3 (el) |
ES (1) | ES2771486T3 (el) |
HR (1) | HRP20200039T1 (el) |
HU (1) | HUE047900T2 (el) |
LT (1) | LT3419598T (el) |
MX (1) | MX2018011217A (el) |
PL (1) | PL3419598T3 (el) |
PT (1) | PT3419598T (el) |
RS (1) | RS59873B1 (el) |
RU (1) | RU2018134749A (el) |
SI (1) | SI3419598T1 (el) |
WO (1) | WO2017158099A1 (el) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3219305A1 (de) * | 2016-03-16 | 2017-09-20 | Apostolos Georgopoulos | Fosfomycin-formulierung zur parenteralen verabreichung |
KR20210148496A (ko) * | 2020-05-28 | 2021-12-08 | 제주대학교 산학협력단 | 포스포마이신을 이용한 멜라닌 저색소증 개선제 조성물 |
TWI796597B (zh) * | 2020-09-21 | 2023-03-21 | 長庚大學 | 使用紫蘇之經水萃取的產物來對抗冠狀病毒感染的方法 |
EP4268805A1 (de) * | 2022-04-29 | 2023-11-01 | Apostolos Georgopoulos | Fosfomycin-formulierung zur parenteralen verabreichung und herstellungsverfahren |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3602145C1 (de) | 1986-01-24 | 1993-04-15 | Buender Glas Gmbh | Ampulle auf Glas |
DE3823428A1 (de) | 1988-07-11 | 1990-01-18 | Hansen Bernd | Ampulle aus kunststoff |
JP2006516235A (ja) | 2003-01-09 | 2006-06-29 | バクスター・ヘルスケヤー・ソシエテ・アノニム | 生物活性物質用の安全容器およびその容器を製造するための方法 |
JP2007502329A (ja) * | 2003-05-23 | 2007-02-08 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | セルトラリン組成物 |
PT2316419E (pt) * | 2004-05-17 | 2012-10-22 | Gilead Sciences Inc | Combinação de fosfomicina/aminoglicósido em aerossol para o tratamento de infeções respiratórias bacterianas |
DE102004063764A1 (de) | 2004-12-29 | 2006-07-13 | Hexal Ag | Kunststoff-Flasche für Oxaliplatin |
EP2101787B1 (en) | 2006-12-11 | 2013-09-18 | Drugrecure ApS | Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin |
CH697917B1 (de) | 2007-09-21 | 2012-03-30 | Franz Dr Marschall | Verpackungseinheit zur Bereitstellung einer parenteral verabreichbaren, pharmakologisch akzeptablen pharmazeutischen Formulierung. |
DE102007056462B4 (de) | 2007-11-23 | 2011-10-27 | Pari Pharma Gmbh | Einwegampulle für eine Vorrichtung zur Erzeugung von Aerosolen |
CA2741306A1 (en) | 2008-10-21 | 2010-04-29 | Gilead Sciences, Inc. | Fosfomycin/tobramycin combinations for the treatment and prevention of ophthalmic, otological and dermatological infections |
WO2012030513A2 (en) | 2010-08-30 | 2012-03-08 | Cempra Pharmaceuticals Inc. | Methods of treating bacterial infections through pulmonary delivery of fusidic acid |
EA021876B1 (ru) | 2010-09-20 | 2015-09-30 | ЛИМОНОВ, Виктор Львович | Фармацевтическая композиция антимикробного и противовоспалительного действия для парентерального введения, способ ее получения |
EP2708219A1 (en) | 2012-09-12 | 2014-03-19 | PARI Pharma GmbH | Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element |
TWI571259B (zh) * | 2013-03-15 | 2017-02-21 | 卡帝俄斯製藥公司 | 胺基糖苷及磷黴素組合之改良調配物及用於治療呼吸器相關性肺炎(vap)與呼吸器相關性氣管(vat)支氣管炎之方法及系統 |
CN103251634A (zh) * | 2013-05-27 | 2013-08-21 | 关卫 | 磷霉素钠/舒巴坦钠注射剂 |
CN103356663A (zh) * | 2013-06-28 | 2013-10-23 | 浙江省农业科学院 | 兽用磺胺间甲氧嘧啶-环丙沙星-磷霉素联合注射液及其制备方法 |
US9486462B2 (en) | 2013-08-26 | 2016-11-08 | Cardeas Pharma Corporation | Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties |
WO2015070131A1 (en) * | 2013-11-11 | 2015-05-14 | Forest Laboratories Holdings Limited | Compositions and methods of treatment comprising fosfomycin disodium |
EP3219305A1 (de) * | 2016-03-16 | 2017-09-20 | Apostolos Georgopoulos | Fosfomycin-formulierung zur parenteralen verabreichung |
-
2016
- 2016-03-16 EP EP16160698.3A patent/EP3219305A1/de not_active Withdrawn
-
2017
- 2017-03-16 WO PCT/EP2017/056252 patent/WO2017158099A1/de active Application Filing
- 2017-03-16 PT PT177103157T patent/PT3419598T/pt unknown
- 2017-03-16 RS RS20200103A patent/RS59873B1/sr unknown
- 2017-03-16 MX MX2018011217A patent/MX2018011217A/es unknown
- 2017-03-16 DK DK17710315.7T patent/DK3419598T3/da active
- 2017-03-16 SI SI201730181T patent/SI3419598T1/sl unknown
- 2017-03-16 US US16/082,590 patent/US10675291B2/en active Active
- 2017-03-16 PL PL17710315T patent/PL3419598T3/pl unknown
- 2017-03-16 CA CA3014503A patent/CA3014503A1/en active Pending
- 2017-03-16 ES ES17710315T patent/ES2771486T3/es active Active
- 2017-03-16 EP EP19197649.7A patent/EP3603618A1/de not_active Withdrawn
- 2017-03-16 BR BR112018068510-0A patent/BR112018068510A2/pt active Search and Examination
- 2017-03-16 KR KR1020187026081A patent/KR20180122346A/ko not_active Application Discontinuation
- 2017-03-16 AU AU2017235463A patent/AU2017235463A1/en not_active Abandoned
- 2017-03-16 RU RU2018134749A patent/RU2018134749A/ru not_active Application Discontinuation
- 2017-03-16 CN CN201780016929.5A patent/CN108883062A/zh active Pending
- 2017-03-16 EP EP17710315.7A patent/EP3419598B1/de active Active
- 2017-03-16 LT LTEP17710315.7T patent/LT3419598T/lt unknown
- 2017-03-16 HU HUE17710315A patent/HUE047900T2/hu unknown
- 2017-03-16 JP JP2019500015A patent/JP2019511573A/ja active Pending
-
2020
- 2020-01-09 HR HRP20200039TT patent/HRP20200039T1/hr unknown
- 2020-02-05 CY CY20201100110T patent/CY1123109T1/el unknown
- 2020-05-08 US US16/869,646 patent/US10993951B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3419598A1 (de) | 2019-01-02 |
KR20180122346A (ko) | 2018-11-12 |
JP2019511573A (ja) | 2019-04-25 |
US20190070202A1 (en) | 2019-03-07 |
HUE047900T2 (hu) | 2020-05-28 |
RU2018134749A (ru) | 2020-04-16 |
US10675291B2 (en) | 2020-06-09 |
DK3419598T3 (da) | 2020-02-10 |
CA3014503A1 (en) | 2017-09-21 |
MX2018011217A (es) | 2019-03-28 |
HRP20200039T1 (hr) | 2020-05-29 |
LT3419598T (lt) | 2020-02-10 |
PL3419598T3 (pl) | 2020-05-18 |
RS59873B1 (sr) | 2020-03-31 |
PT3419598T (pt) | 2020-02-18 |
EP3419598B1 (de) | 2019-11-06 |
US20200261478A1 (en) | 2020-08-20 |
WO2017158099A1 (de) | 2017-09-21 |
ES2771486T3 (es) | 2020-07-06 |
EP3603618A1 (de) | 2020-02-05 |
EP3219305A1 (de) | 2017-09-20 |
SI3419598T1 (sl) | 2020-03-31 |
RU2018134749A3 (el) | 2020-05-21 |
US10993951B2 (en) | 2021-05-04 |
BR112018068510A2 (pt) | 2021-04-13 |
AU2017235463A1 (en) | 2018-09-27 |
CN108883062A (zh) | 2018-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123109T1 (el) | Σκευασμα φωσφομυκινης για παρεντερικη χορηγηση | |
CY1123825T1 (el) | Συνθεσεις μαγνησιου για ρυθμιση της φαρμακοκινητικων και φαρμακοδυναμικων ινσουλινης, και πονου θεσης ενεσης | |
ZA202102906B (en) | Liquid protein formulations containing viscosity-lowering agents | |
CY1118826T1 (el) | Διαδικασια για την κατασκευη ενος φαρμακευτικου σκευασματος που περιεχει glatiramer acetate | |
CY1121698T1 (el) | Υγρο σκευασμα για εισπνοη που περιεχει rpl554 | |
CA2646163A1 (en) | 3,7-diamino-10h-phenothiazine salts and their use | |
BR112018014027A2 (pt) | composições e métodos para administração intravenosa de 2-bromo-1-(3,3-dinitroazeditin-1-il)etanona | |
WO2015128403A3 (en) | An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human insulin analogue | |
CY1124493T1 (el) | Υγρη φαρμακευτικη συνθεση | |
MX2021003724A (es) | Profarmaco de nitroxolina y su uso. | |
SI3166925T1 (en) | Isoindoline derivatives for use in treating a viral infection | |
CY1120488T1 (el) | Υγρη φαρμακευτικη συνθεση | |
CY1123847T1 (el) | Διαδικασια για τη βαρυμετρικη πληρωση, σε συνθηκες αποστειρωσης, στερεων σε φαρμακευτικο δοχειο | |
CY1121921T1 (el) | Φαρμακευτικα σκευασματα | |
BR112021022889A2 (pt) | Derivados heterocíclicos fundidos | |
MX2020014262A (es) | Composicion farmaceutica que comprende un agente basico poco soluble. | |
EA201700426A3 (ru) | Способ производства нестерильных субстанций безводного "тамерита" и/или двухводного "галавита" - натриевых солей 5-амино-2,3-дигидрофталазин-1,4-диона (варианты) и способы дальнейшей их переработки в стерильные лекарственные препараты | |
CO2021002433A2 (es) | Un método de obtención de la forma de dosis líquida del medicamento edaravone, que es estable durante el almacenamiento, transporte y de uso conveniente | |
BR112018016287A2 (pt) | sistema de perfusão, método para administrar diretamente a um paciente em necessidade do mesmo uma dose de um fármaco antineoplásico e recipiente de perfusão | |
MX2013009359A (es) | Sistema de administracion de seguridad de cefuroxima. | |
WO2016005740A3 (en) | A masking package | |
BR112017012975A2 (pt) | formulações injetáveis de paracetamol | |
TH1801004716A (th) | ระบบการกำซาบ(Perfusionsystem) | |
Devi | Intravenous Medication Safety and Role of Pharmacist | |
TH144099A (th) | ระบบการนำส่งที่มีความปลอดภัยของเซฟูรอกซีม |